In Phase A, individuals will get different doses and schedules of oral ABBV-744 tablet to discover safe dosing regimen. More contributors is going to be enrolled within the identified monotherapy dosign regimen. In Section B, members will obtain oral ruxolitinib and ABBV-744 might be offered as "insert-on" therapy. In Phase https://clinical-effectiveness-of79023.techionblog.com/31947752/5-essential-elements-for-abbv-744-drug-development-progress-and-timeline